0001127602-19-030039.txt : 20191003
0001127602-19-030039.hdr.sgml : 20191003
20191003172254
ACCESSION NUMBER: 0001127602-19-030039
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191001
FILED AS OF DATE: 20191003
DATE AS OF CHANGE: 20191003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Burke William P. Mr.
CENTRAL INDEX KEY: 0001682069
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14041
FILM NUMBER: 191136662
MAIL ADDRESS:
STREET 1: HAEMONETICS CORPORATION
STREET 2: 400 WOOD ROAD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
FORMER NAME:
FORMER CONFORMED NAME: Burke Willaim P
DATE OF NAME CHANGE: 20160810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HAEMONETICS CORP
CENTRAL INDEX KEY: 0000313143
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042882273
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0328
BUSINESS ADDRESS:
STREET 1: 400 WOOD RD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
BUSINESS PHONE: 7818487100
MAIL ADDRESS:
STREET 1: 400 WOOD ROAD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2019-10-01
0000313143
HAEMONETICS CORP
HAE
0001682069
Burke William P. Mr.
400 WOOD ROAD
BRAINTREE
MA
02184
1
EVP, Chief Financial Officer
Common Stock
2019-10-01
4
M
0
5718
41.64
A
20178
D
Common Stock
2019-10-01
4
S
0
3070
124.47
D
17108
D
Common Stock
2019-10-01
4
S
0
1309
125.71
D
15799
D
Common Stock
2019-10-01
4
S
0
1670
126.72
D
14129
D
Common Stock
2019-10-01
4
S
0
648
127.80
D
13481
D
Common Stock
2019-10-01
4
S
0
467
128.66
D
13014
D
Non-qualified Stock Option (Right to Buy)
41.64
2019-10-01
4
M
0
5718
0
D
2018-06-06
2024-06-06
Common Stock
5718
11435
D
Transaction pursuant to an existing 10b5-1 trading plan.
This number includes unvested RSUs previously reported.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.21 to $124.98, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (7) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.24 to $126.16, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.29 to $127.18, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.31 to $127.99, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.55 to $129.00, inclusive.
Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
/s/ Thomas V. Powers, attorney-in-fact for Mr. Burke
2019-10-03